Zobrazeno 1 - 10
of 262
pro vyhledávání: '"Arlene O. Siefker‐Radtke"'
Autor:
Arlene O. Siefker-Radtke, Andrea Necchi, Se Hoon Park, Jesús García-Donas, Robert A. Huddart, Earle F. Burgess, Mark T. Fleming, Arash Rezazadeh Kalebasty, Begoña Mellado, Sergei Varlamov, Monika Joshi, Ignacio Duran, Scott T. Tagawa, Yousef Zakharia, Keqin Qi, Sydney Akapame, Spyros Triantos, Anne O'Hagan, Yohann Loriot
Publikováno v:
European Urology Open Science, Vol 50, Iss , Pp 1-9 (2023)
Background: Erdafitinib is indicated for the treatment of adults with locally advanced/metastatic urothelial carcinoma and susceptible FGFR3/2 alterations progressing on/after one or more lines of prior platinum-based chemotherapy. Objective: To bett
Externí odkaz:
https://doaj.org/article/859488fb49644ff6bbf4afa1b1012ee4
Autor:
Omar Alhalabi, Matthew T. Campbell, Lianchun Xiao, Ana C. Adriazola, Nathaniel R. Wilson, Arlene O. Siefker‐Radtke, Paul G. Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M. Kamat, Neema Navai, Louis L. Pisters, Colin Dinney, Surena F. Matin, Amishi Y. Shah
Publikováno v:
BJUI Compass, Vol 3, Iss 1, Pp 37-44 (2022)
Abstract Objectives Multimodal kidney‐preserving (MKP) strategies may be an option for patients with localised or locally advanced high‐risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU).
Externí odkaz:
https://doaj.org/article/4bec1710d1984582ada90fc20a09d76b
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
Autor:
Mario Sznol, Adi Diab, Jonathan Zalevsky, Ute Hoch, Mehmet A Bilen, Giovanni Grignani, Nizar M Tannir, Erika Puente, Arjun V Balar, Daniel C Cho, Arlene O Siefker-Radtke, Lily Tang, David Chien, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Michael E Hurwitz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/b068e058e3794225a3c64c98a9d5c726
Autor:
Arlene O. Siefker-Radtke, Daniel C. Cho, Adi Diab, Mario Sznol, Mehmet A. Bilen, Arjun V. Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L. Currie, Mary A. Tagliaferri, Jonathan Zalevsky, Michael E. Hurwitz, Nizar M. Tannir
Publikováno v:
European Urology. 82:365-373
Despite recent changes in the treatment landscape, there remains an unmet need for effective, tolerable, chemotherapy-free treatments for patients with advanced/metastatic urothelial carcinoma (mUC), especially cisplatin-ineligible patients.To evalua
Autor:
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam Chang, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman-Censits, Amar Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle Richards, Wade J. Sexton, Arlene O. Siefker-Radtke, Matthew Tollefson, Jonathan Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:866-878
The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract cancers (upper tract tumors, urothelial carcinoma of the prostate, primary
Autor:
Eddie K. Abdalla, Jitesh Ahuja, Felipe Aluja-Jaramillo, Rodabe N. Amaria, Behrang Amini, Anca Avram, Rony Avritscher, Isabelle Bedrosian, Sonia L. Betancourt-Cuellar, Priya R. Bhosale, Andrew J. Bishop, Yulia Bronstein, Constantine M. Burgan, Hop S. Tran Cao, Sudpreeda Chainitikun, Joe Y. Chang, Lisly J.Chery, Hubert H. Chuang, Aaron Coleman, Colleen M. Costelloe, Prajnan Das, Reordan DeJesus, Catherine Devine, Patricia J. Eifel, Jeremy J. Erasmus, Silvana C.Faria, Jason B. Fleming, Samuel J. Galgano, Dhakshinamoorthy Ganeshan, Naveen Garg, Patrick B. Garvey, Gregory Gladish, Chunxiao Guo, Fernando R. Gutiérrez, Daniel M. Halperin, Abdelrahman K. Hanafy, Karen Hoffman, Wayne L. Hofstetter, Wen-Jen Hwu, Juan J. Ibarra Rovira, Mohannad Ibrahim, Naruhiko Ikoma, Revathy B. Iyer, Sanaz Javadi, Milind Javle, Corey T. Jensen, Eric Jonasch, Aparna Kamat, Ashish Kamat, Avinash R. Kambadakone, Gregory P. Kaufman, Amritjot Kaur, Harmeet Kaur, Brinda Rao Korivi, Rajendra Kumar, Vikas Kundra, Marcelo F. Kuperman Benveniste, Ott Le, Jeffrey H. Lee, Huang LePetross, Patrick P. Lin, Joseph A. Ludwig, Homer A. Macapinlac, John E. Madewell, Paul Mansfield, Leonardo P. Marcal, Edith M. Marom, Tara Massini, Aurelio Matamoros, Mary Frances McAleer, Reza J. Mehran, Christine Menias, Ajaykumar C. Morani, Van K. Morris, Stacy L. Moulder-Thompson, Bilal Mujtaba, Suresh K. Mukherji, Sameh Nassar, Quynh-Nhu Nguyen, Yoshifumi Noda, Amir Onn, Michael J. Overman, Lance C. Pagliaro, Diana P. Palacio, Anushri Parakh, Hemant A. Parmar, Shreyaskumar Patel, Madhavi Patnana, Alexandria Phan, Halyna Pokhylevych, Kristin K. Porter, Gaiane M. Rauch, Bharat Raval, Miguel Rodriguez-Bigas, Eric M. Rohren, Christina L. Roland, Jeremy Ross, Bradley S. Sabloff, Tara Sagebiel, Dushant V. Sahani, Kathleen M. Schmeler, Girish Shroff, Arlene O Siefker-Radtke, Elainea N. Smith, R. Jason Stafford, David J. Stewart, Chad D. Strange, Stephen G. Swisher, Ahmed Taher, Cher Heng Tan, Mylene T. Truong, Naoto T. Ueno, Gauri R. Varadhachary, Aradhana M. Venkatesan, Claire F. Verschraegen, Raghunandan Vikram, Sarah J.Vinnicombe, Mayur K. Virarkar, Chitra Viswanathan, Jason R. Westin, Wendy A. Woodward, T. Kuan Yu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28a5c8227639b2784debc675d001af69
https://doi.org/10.1016/b978-0-323-69538-1.00047-1
https://doi.org/10.1016/b978-0-323-69538-1.00047-1
Autor:
Filip Janku, Matthew T. Campbell, Siqing Fu, Funda Meric-Bernstam, Timothy A. Yap, Andrew W. Hahn, Arlene O. Siefker-Radtke, Hung Le, Sarina Anne Piha-Paul, Vivek Subbiah, Nathaniel R. Wilson, Omar Alhalabi, Nizar M. Tannir, Kimberly Beltran, David S. Hong, Shubham Pant, Erick Campbell, Jianjun Gao, Janos Roszik, Pavlos Msaouel, Amishi Yogesh Shah, Aung Naing, Daniel D. Karp
Publikováno v:
Clinical Genitourinary Cancer. 20:e16-e24
Introduction Enrolling patients with metastatic urothelial carcinoma (mUC) in phase I trials provides an opportunity to identify biological drug activity. Developing prognostic scores may aid in patient selection for phase 1 trials. Patients and Meth
Autor:
Matthew T. Campbell, Andrea Kokorovic, Jianjun Gao, Charles C. Guo, Patrick J. Hensley, Arlene O. Siefker-Radtke, Graciela M. Nogueras-Gonzalez, Tanner Miest, Kelly K. Bree, Neema Navai, Ashish M. Kamat, Colin P.N. Dinney, Omar Alhalabi
Publikováno v:
Journal of Urology. 206:1258-1267
Purpose:Data from the pre-neoadjuvant chemotherapy (NAC) era suggests patients who progress on bacillus Calmette-Guerin (BCG) to muscle-invasive bladder cancer (P-MIBC) exhibit worse outcomes compa...
Autor:
Arash Rezazadeh Kalebasty, David J. Benjamin, Yohann Loriot, Dimitrios Papantoniou, Arlene O. Siefker-Radtke, Andrea Necchi, Vahid Naini, Jenna Cody Carcione, Ademi Santiago-Walker, Spyros Triantos, Earle F. Burgess
Publikováno v:
European urology open science. 47
Clinical outcomes of anti-programmed death‑(ligand) 1 (anti-PD-[L]1) therapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) and fibroblast growth factor receptor alterations (To analyze the outcomes of patients with mUC